MARKET INTRODUCTION
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine. In personalized medicine, diagnostic analysis is often conducted for selecting suitable and best treatments based on the patient's genetic content or other molecular or cellular analysis. Personalized medicine has best response and highest safety margin to ensure enhanced patient care by allowing every patient to attain earlier diagnosis, risk assessment, and best treatment. Additionally, personalized medicine offers opportunities to improve health care by lowering overall treatment costs.
MARKET DYNAMICS
The personalized medicine market is anticipated to grow due to availability of a wide range of nutrition & wellness products and increased Over the Counter (OTC) sale of these products. However, high competition among existing market players, and lack of awareness among the rural population in developing economies are restraining the market growth. Moreover, rise in the prevalence of various types of cancer, affordability of personalized medicine therapy in cancer drugs and various other disease indications is expected to benefit the growth of the market in the forecast period.
MARKET SCOPE
The "Personalized Medicine Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in personalized medicine market with detailed market segmentation by product and geography. The personalized medicine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in personalized medicine market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The personalized medicine market is segmented on the basis of product. Based on product the market is segmented as PM diagnostics, PM therapeutics, personalized medical care, and personalized nutrition & wellness. Further, on the basis of PM diagnostics the market is categorized as genetic testing, DTC diagnostics, esoteric lab services and esoteric lab tests. Further, on the basis of PM therapeutics the market is categorized as pharmaceutical, genomic medicine and medical devices. Further, on the basis of personalized medical care the market is categorized as telemedicine, heath information technology and diseases management. Further, on the basis of personalized nutrition & wellness the market is categorized as retail nutrition, complementary medicine and alternative medicine.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in personalized medicine market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The personalized medicine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting personalized medicine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the personalized medicine market in these regions.
By Product
MARKET PLAYERS
The report covers key developments in the in personalized medicine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in personalized medicine market are anticipated to have lucrative growth opportunities in the future with the rising demand for in personalized medicine market in the global market. Below mentioned is the list of few companies engaged in the personalized medicine market.
The report also includes the profiles of key in personalized medicine market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott Laboratories
- Amgen, Inc.
- AstraZeneca
- Bayer AG
- Eli Lilly and Company
- GlaxoSmithKline plc.
- Merck & Co., Inc
- Mylan N.V.
- Novartis AG
- Pfizer, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine. In personalized medicine, diagnostic analysis is often conducted for selecting suitable and best treatments based on the patient's genetic content or other molecular or cellular analysis. Personalized medicine has best response and highest safety margin to ensure enhanced patient care by allowing every patient to attain earlier diagnosis, risk assessment, and best treatment. Additionally, personalized medicine offers opportunities to improve health care by lowering overall treatment costs.
MARKET DYNAMICS
The personalized medicine market is anticipated to grow due to availability of a wide range of nutrition & wellness products and increased Over the Counter (OTC) sale of these products. However, high competition among existing market players, and lack of awareness among the rural population in developing economies are restraining the market growth. Moreover, rise in the prevalence of various types of cancer, affordability of personalized medicine therapy in cancer drugs and various other disease indications is expected to benefit the growth of the market in the forecast period.
MARKET SCOPE
The "Personalized Medicine Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in personalized medicine market with detailed market segmentation by product and geography. The personalized medicine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in personalized medicine market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The personalized medicine market is segmented on the basis of product. Based on product the market is segmented as PM diagnostics, PM therapeutics, personalized medical care, and personalized nutrition & wellness. Further, on the basis of PM diagnostics the market is categorized as genetic testing, DTC diagnostics, esoteric lab services and esoteric lab tests. Further, on the basis of PM therapeutics the market is categorized as pharmaceutical, genomic medicine and medical devices. Further, on the basis of personalized medical care the market is categorized as telemedicine, heath information technology and diseases management. Further, on the basis of personalized nutrition & wellness the market is categorized as retail nutrition, complementary medicine and alternative medicine.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in personalized medicine market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The personalized medicine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting personalized medicine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the personalized medicine market in these regions.
Personalized Medicine Market Report Analysis
Personalized Medicine Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Abbott Laboratories
- Amgen, Inc.
- AstraZeneca
- Bayer AG
- Eli Lilly and Company
- GlaxoSmithKline plc.
- Merck & Co., Inc
- Mylan N.V.
- Novartis AG
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Product
- PM Diagnostics
- PM Therapeutics
- Personalized Medical Care
- Personalized Nutrition and Wellness
The report covers key developments in the in personalized medicine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in personalized medicine market are anticipated to have lucrative growth opportunities in the future with the rising demand for in personalized medicine market in the global market. Below mentioned is the list of few companies engaged in the personalized medicine market.
The report also includes the profiles of key in personalized medicine market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott Laboratories
- Amgen, Inc.
- AstraZeneca
- Bayer AG
- Eli Lilly and Company
- GlaxoSmithKline plc.
- Merck & Co., Inc
- Mylan N.V.
- Novartis AG
- Pfizer, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Personalized Medicine Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ XX Million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2023 - 2031) | XX% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Hydrogen Storage Alloys Market
- Industrial Inkjet Printers Market
- Medical Collagen Market
- Terahertz Technology Market
- MEMS Foundry Market
- Dealer Management System Market
- Environmental Consulting Service Market
- Nurse Call Systems Market
- Health Economics and Outcome Research (HEOR) Services Market
- Single Pair Ethernet Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies
1. Abbott Laboratories
2. Amgen, Inc.
3. AstraZeneca
4. Bayer AG
5. Eli Lilly and Company
6. GlaxoSmithKline plc.
7. Merck & Co., Inc
8. Mylan N.V.
9. Novartis AG
10. Pfizer, Inc.
1. Abbott Laboratories
2. Amgen, Inc.
3. AstraZeneca
4. Bayer AG
5. Eli Lilly and Company
6. GlaxoSmithKline plc.
7. Merck & Co., Inc
8. Mylan N.V.
9. Novartis AG
10. Pfizer, Inc.
Get Free Sample For